Shenzhen Transsion Holdings Co., Ltd. (SHA:688036)

Verve Therapeutics Revenue

Shenzhen Transsion Holdings had revenue of 13.00B CNY in the quarter ending March 31, 2025, a decrease of -25.45%. This brings the company's revenue in the last twelve months to 64.28B, down -8.78% year-over-year. In the year 2024, Shenzhen Transsion Holdings had annual revenue of 68.72B with 10.31% growth.

• Revenue (ttm): 64.28B
• Revenue Growth: -8.78%
• P/S Ratio: 1.40
• Revenue / Employee: 3.23M
• Employees: 19,870
• Market Cap: 90.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	68.72B	6.42B	10.31%
Dec 31, 2023	62.29B	15.70B	33.69%
Dec 31, 2022	46.60B	-2.82B	-5.70%
Dec 31, 2021	49.41B	11.62B	30.75%
Dec 31, 2020	37.79B	12.45B	49.10%